Chemotherapy and radiation therapy of multiple myeloma (program ID: 126047)
University Hospital Rechts der Isar Munich
Florian BassermannSpecialized in: hematology, oncology
Department of Hematology and Oncology
- Initial presentation in the clinic
- clinical history taking
- review of medical records
- physical examination
- laboratory tests:
- complete blood count
- biochemical analysis of blood
- urinalysis for Bence Jones protein
- differential blood count
- protein electrophoresis
- TSH-basal, fT3, fT4
- inflammation indicators (CRP, ESR)
- indicators of blood coagulation
- CT-planning of radiation therapy
- full course of conventional radiation therapy
- individual plan of chemotherapy, the cost of medicines is included
- symptomatic treatment
- cost of essential medicines and materials
- nursing services
- control examinations
- consultations of related specialists
How program is carried out
During the first visit, the doctor will conduct a clinical examination and go through the results of previous laboratory tests and instrumental examinations. After that, you will undergo an additional examination, including complete blood count, laboratory assessment of liver and kidney function. Based on the received results, the physician will elaborate the chemotherapy regimen, conduct radiotherapy planning with the help of CT or MRI, make the permanent tattoo marks on the skin and conduct CT simulation in order to assess the accuracy of the rays and the radiation dose. If necessary, related medical specialists will be involved in the elaboration of a treatment regimen (tumor board).
Chemotherapy and radiation therapy are carried out as the day hospital procedure, without mandatory admission to the hospital. At each visit, the physician will assess your general condition and the marks on the skin. After that, you will be placed in a shielded radiation therapy room, on a special table.
Each radiation therapy session lasts less than half an hour (including preparation). All this time, doctors and nurses are monitoring your condition, you can communicate with them through a loudspeaker. The procedure is completely painless. Depending on the planned course of treatment, you will visit the hospital from 1 to 3-5 times a week.
During the chemotherapy session, after the placement of a venous catheter, you will stay in a comfortable ward. An infusion system will be connected to the catheter, through which the required drug or a drug combination will be administered. All drugs are administered by intravenous drip, slowly, so the total duration of the infusion can be up to several hours. All this time, doctors and nurses will monitor your health condition closely.
After the completion of the chemotherapy and radiation therapy course, you will undergo control examinations aimed at assessing your condition and efficacy of treatment. After that you will receive the medical report with detailed recommendations regarding further follow-up and treatment. In the future, you will be able to have a distant consultation with your attending physician and schedule the next course of treatment, if necessary.
- Medical records
- MRI/CT scan (not older than 3 months)
- Bone marrow biopsy results (if available)
You may also book
About the department
The Department of Hematology and Oncology at the University Hospital Rechts der Isar Munich offers the full range of diagnostic and therapeutic services in these focuses. A highly qualified team of doctors working in the department provides patients with an effective treatment of all cancers, blood and lymph pathologies (for example, leukemia, multiple myeloma, non-Hodgkin's and Hodgkin's lymphoma) in accordance with the latest international therapeutic standards. The department is headed by Prof. Dr. med. Florian Bassermann.
It should be noted that the department is certified by the Comprehensive Cancer Center Munich. The department is fitted out with the state-of-the-art technical equipment, has innovative treatment methods, but also pays key attention to comprehensive consultations and human attitude towards patients. It provides special consultations on nutrition, competent psycho-oncological care.
The treatment strategy is developed at the interdisciplinary tumor boards with the participation of hematologists, oncologists, surgeons, radiation therapists, radiologists, specialists in pathological anatomy and nuclear medicine, due to which each patient can receive an optimal treatment plan corresponding to his/her specific clinical case. The main therapeutic options of the department include classical chemotherapy, high-dose chemotherapy, targeted therapy, multimodal therapy, immunotherapy, radiation therapy, combined chemoradiotherapy, surgical treatments, etc.
The department provides both diagnostics and treatment of the following diseases:
- Acute and chronic leukemia
- Malignant lymphomas (Hodgkin's lymphoma and non-Hodgkin's lymphomas)
- Multiple myeloma (plasmacytoma)
- Small cell and non-small cell lung cancer
- Chronic myeloproliferative diseases
- Myelodysplastic syndrome (MDS)
- Gastrointestinal tumors (tumors of the esophagus, stomach, pancreas, large intestine)
- Gastrointestinal stromal tumors
- Bone and soft tissue tumors (sarcomas)
- Gynecologic oncology
- Head and neck tumors
- Testicular tumors
- Other diseases
Prof. Bassermann studied medicine in Ulm, Munich and New York. He received his doctor’s degree at the Technical University of Munich. Prior to becoming a Postdoctoral Fellow at the New York University (2006 - 2009), the doctor began his clinical and scientific activities at the Technical University of Munich. After his return to the Technical University of Munich he has headed the Emmy Noether Junior Research Group (funding from the German Research Foundation). Here he was also recognized as a Medical Specialist in Internal Medicine, Hematology and Oncology, as well as had his habilitation. In 2011, he was appointed a Senior Physician, whereas in 2015 received an invitation to the position of Professor at the Technical University of Munich. Since November 2017, Prof. Bassermann has been heading the Department of Hematology and Oncology at the University Hospital Rechts der Isar Munich.
Most Significant Awards
- 2015 ERC Consolidator Grant.
- 2015 Langener Research Award.
- 2015 Theodor Frerichs Award, German Society of Internal Medicine (DGIM).
- 2010 Walther Flemming Medal, German Society of Cell Biology (DGZ).
- 2009 Participation in the Emmy Noether Program of the German Research Foundation.
Photo of the doctor: (c) Klinikum rechts der Isar der Technischen Universität München
Accommodation in hospital
- Program [Description]
Chemotherapy and radiation therapy of multiple myeloma
- Hospital: University Hospital Rechts der Isar Munich
- access_time Duration:
There are 63 multiple myeloma treatment hospitals on Booking Health websiteShow all clinics